Scientists have developed a new and effective method for measuring the activity of beta-carotene 15,15′-dioxygenase, an enzyme critical in the conversion of beta-carotene into retinal, a form of vitamin A. The technique utilizes reverse-phase high-performance liquid chromatography (HPLC) to provide precise assessments of enzymatic activity in various biological samples.
Beta-carotene 15,15′-dioxygenase plays an essential role in vitamin A metabolism, which is vital for vision, cellular growth, and immune function. Accurate measurement of its activity is important for both nutritional studies and the understanding of diseases associated with vitamin A deficiency and metabolism.
Traditionally, evaluating the activity of this enzyme has posed challenges due to the complexity of sample preparation and limitations in detection sensitivity. The new reverse-phase HPLC method addresses these issues by enhancing the separation of the enzyme’s products from its substrate and other sample components, leading to greater accuracy and reproducibility.
In this method, samples are prepared and incubated under controlled conditions, after which the reaction products are extracted and analyzed using reverse-phase HPLC. The technique allows for the clear identification and quantification of retinal, the primary product of beta-carotene cleavage, providing a direct measure of enzyme activity.
Researchers believe this advancement could significantly benefit studies in nutrition science, pharmacology, and medical diagnostics. It may also aid in evaluating the efficacy of dietary supplements and therapeutic approaches aimed at influencing vitamin A levels in the body.
This methodological innovation offers a promising tool for researchers worldwide, enhancing the understanding of vitamin A-related metabolic pathways and contributing to improved public health outcomes.
Source: https:// – Courtesy of the original publisher.
